Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$521M |
| 2 |
Becton Dickinson
BDX
|
+$411M |
| 3 |
GE Aerospace
GE
|
+$361M |
| 4 |
IBM
IBM
|
+$305M |
| 5 |
Philip Morris
PM
|
+$296M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BCR
CR Bard Inc.
BCR
|
+$455M |
| 2 |
NetEase
NTES
|
+$451M |
| 3 |
Medtronic
MDT
|
+$398M |
| 4 |
NVIDIA
NVDA
|
+$348M |
| 5 |
Netflix
NFLX
|
+$332M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.06% |
| 2 | Technology | 13.71% |
| 3 | Financials | 10.21% |
| 4 | Industrials | 9.72% |
| 5 | Consumer Discretionary | 9.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
951
Celanese
CE
$4.75B
| $19.6M | 0.02% |
182,800
+46,900
| +35% | +$4.98M |
|
|
CRCM
952
DELISTED
CARE.COM, INC.
CRCM
| $19.5M | 0.02% |
1,082,700
+170,000
| +19% | +$2.98M |
|
953
Hartford Financial Services
HIG
$37.7B
| $19.5M | 0.02% |
346,100
-5,000
| -1% | -$279K |
|
954
Integra LifeSciences
IART
$1.35B
| $19.4M | 0.02% |
405,800
+194,900
| +92% | +$9.54M |
|
955
Cousins Properties
CUZ
$4.85B
| $19.4M | 0.02% |
524,418
+212,850
| +68% | +$7.86M |
|
|
BSTC
956
DELISTED
BioSpecifics Technologies Corp.
BSTC
| $19.4M | 0.02% |
447,186
+31,886
| +8% | +$1.43M |
|
957
Strategic Education
STRA
$1.81B
| $19.4M | 0.02% |
216,100
-84,200
| -28% | -$7.78M |
|
|
SASR
958
DELISTED
Sandy Spring Bancorp Inc
SASR
| $19.3M | 0.02% |
495,654
-8,300
| -2% | -$333K |
|
959
Terreno Realty
TRNO
$7.48B
| $19.3M | 0.02% |
551,400
+33,900
| +7% | +$1.25M |
|
960
Visa
V
$671B
| $19.3M | 0.02% |
+169,000
| New | +$18.7M |
|
|
ARNA
961
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $19.2M | 0.02% |
565,650
-329,516
| -37% | -$9.39M |
|
962
Antero Resources
AR
$11.5B
| $19.2M | 0.02% |
1,010,300
+276,300
| +38% | +$5.3M |
|
|
CHMI
963
Cherry Hill Mortgage Investment Corp
CHMI
$107M
| $19.2M | 0.02% |
1,066,600
-91,350
| -8% | -$1.67M |
|
|
MSCC
964
DELISTED
Microsemi Corp
MSCC
| $19.2M | 0.02% |
371,301
-24,082
| -6% | -$1.27M |
|
|
CO
965
DELISTED
Global Cord Blood Corporation
CO
| $19.2M | 0.02% |
1,926,500
+320,200
| +20% | +$3.5M |
|
966
Rithm Capital
RITM
$5.71B
| $19.2M | 0.02% |
1,071,405
-493,600
| -32% | -$8.69M |
|
967
Lesaka Technologies
LSAK
$408M
| $19.1M | 0.02% |
1,608,200
-170,000
| -10% | -$1.72M |
|
|
ILG
968
DELISTED
ILG, Inc Common Stock
ILG
| $19.1M | 0.02% |
671,322
-467,907
| -41% | -$13.5M |
|
969
Interactive Brokers
IBKR
$41.5B
| $19.1M | 0.02% |
1,289,200
+423,912
| +49% | +$5.78M |
|
|
ENZ
970
DELISTED
Enzo Biochem, Inc.
ENZ
| $19M | 0.02% |
2,335,800
+197,900
| +9% | +$1.89M |
|
|
SJI
971
DELISTED
South Jersey Industries, Inc.
SJI
| $19M | 0.02% |
607,900
+85,564
| +16% | +$2.83M |
|
972
Reinsurance Group of America
RGA
$16.1B
| $19M | 0.02% |
121,700
+47,700
| +64% | +$7.22M |
|
|
TIME
973
DELISTED
Time Inc.
TIME
| $18.9M | 0.02% |
1,026,000
-714,000
| -41% | -$10.7M |
|
974
NatWest
NWG
$76.7B
| $18.9M | 0.02% |
2,295,986
+1,020,872
| +80% | +$8.16M |
|
975
Gentex
GNTX
$4.93B
| $18.9M | 0.02% |
900,200
+473,700
| +111% | +$9.42M |
|
Similar funds
Jim Simons's Q4 2017 Portfolio in Review
As of Q4 2017, Jim Simons held 3,692 positions worth $90.7B, up 6.7% from $85B the previous quarter. Its ten largest holdings account for 8.4% of the portfolio.
Jim Simons's Q4 2017 filing shows 521 new, 1,724 increased, 1,031 reduced and 386 closed positions. Its largest new stake was Alphabet (Google) Class C: 3,773,700 shares worth $197M. The largest sale was CR Bard Inc., an estimated $455M.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 16% a quarter earlier, followed by Technology and Financials.
- Jim Simons's largest Q4 2017 buy was Alphabet (Google) Class C: 3,773,700 shares worth $197M.
- Jim Simons added most to ExxonMobil in Q4 2017, an estimated $521M increase.
- Jim Simons's biggest Q4 2017 reduction was NetEase, cutting an estimated $451M.
- Jim Simons fully exited CR Bard Inc. in Q4 2017, selling an estimated $455M.
- Jim Simons's ten largest holdings make up 8.4% of its $90.7B portfolio in Q4 2017.
- Jim Simons opened 521 new positions and closed 386 in Q4 2017.
- Jim Simons's portfolio value rose 6.7% quarter-over-quarter to $90.7B.
Based on Renaissance Technologies's 13F filing for Q4 2017, filed 13 Feb 2018.